Countering COVID-19 vaccine myths in pregnancy - Contemporary OB/GYN
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
News|Videos|October 16, 2026 Experts address COVID-19 vaccine myths, safety evidence, and how to frame the benefits of vaccination in pregnancy. Welcome to this Contemporary OB/GYN Special Report series on maternal immunization heading into the 2026-27 respiratory season. Across 5 episodes, our host and experts examine what the latest guidance means in practice for obstetric and pediatric clinicians and for the patients they counsel. Related to this articleOctober 16th, 2026Experts look ahead to new maternal vaccines and how to counsel patients on receiving several in one pregnancy. Read moreOctober 14th, 2026Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns. Read moreOctober 14th, 2026Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients. Read moreOctober 15th, 2026Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake. Read moreOctober 13th, 2026On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.
This article is an excerpt. To read the full content, visit the original source. Contemporary OB/GYN
Related articles
Countering drones is ‘critical’ as warfare evolves, Canada’s military says - Global News
Russia pounds Ukraine, killing at least 24 people Russian missiles and drones pounded Kyiv and other Ukrainian regions, killing at least 24 civilians, including four children, and wounding around 60 – Oct 7, 2026
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!